{{Rsnum
|rsid=2713604
|Gene=GATA2
|Chromosome=3
|position=128481616
|Orientation=minus
|GMAF=0.3049
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=GATA2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 12.4 | 43.4 | 44.2
| HCB | 14.6 | 38.0 | 47.4
| JPT | 18.6 | 47.8 | 33.6
| YRI | 6.1 | 38.1 | 55.8
| ASW | 3.5 | 45.6 | 50.9
| CHB | 14.6 | 38.0 | 47.4
| CHD | 4.6 | 45.0 | 50.5
| GIH | 17.8 | 42.6 | 39.6
| LWK | 2.7 | 30.9 | 66.4
| MEX | 15.5 | 20.7 | 63.8
| MKK | 5.1 | 25.6 | 69.2
| TSI | 8.8 | 41.2 | 50.0
| HapMapRevision=28
}}

[http://genetics.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pgen.0020139 This paper] implicates this snp as playing a role in [[heart disease]]. 

Having a C at this position is considered normal.

Having a T at this position increases the risk of heart disease. Approximate 27% of people carry this risky form.

{{PMID Auto
|PMID=19706030
|Title=Validation Study of Genetic Associations with Coronary Artery Disease on Chromosome 3q13-21 and Potential Effect Modification by Smoking
|OA=1
}}
{{PMID Auto
|PMID=19864173
|Title=Association study of GATA-2 transcription factor gene (GATA2) polymorphism and Parkinson's disease
}}

{{PMID Auto
|PMID=16934006
|Title=GATA2 is associated with familial early-onset coronary artery disease.
|OA=1
}}

{{PMID Auto
|PMID=19885677
|Title=The transcription factor GATA-2 does not associate with angiographic coronary artery disease in the Ottawa Heart Genomics and Cleveland Clinic GeneBank Studies.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}